Insider Transactions in Q1 2021 at Axogen, Inc. (AXGN)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2021
|
Karen L. Zaderej CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
34,500
+4.93%
|
$103,500
$3.67 P/Share
|
|
Feb 25
2021
|
Gregory Gene Freitag Director |
SELL
Open market or private sale
|
Direct |
24,000
-9.51%
|
$528,000
$22.06 P/Share
|
|
Feb 18
2021
|
Michael Patrick Donovan VP Operations |
SELL
Open market or private sale
|
Direct |
1,808
-4.24%
|
$34,352
$19.15 P/Share
|
|
Feb 17
2021
|
Isabelle Billet Chief Strategy and BD Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
454
-3.94%
|
$8,172
$18.71 P/Share
|
|
Feb 17
2021
|
Karen L. Zaderej CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,686
-0.61%
|
$138,348
$18.71 P/Share
|
|
Feb 17
2021
|
Peter J Mariani EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,954
-8.08%
|
$53,172
$18.71 P/Share
|
|
Feb 17
2021
|
Maria D. Martinez Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
406
-6.78%
|
$7,308
$18.71 P/Share
|
|
Feb 17
2021
|
Gregory Gene Freitag Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,577
-0.31%
|
$28,386
$18.7 P/Share
|
|
Feb 17
2021
|
Michael Patrick Donovan VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
797
-0.93%
|
$14,346
$18.71 P/Share
|
|
Feb 17
2021
|
Eric Sandberg Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
903
-21.89%
|
$16,254
$18.7 P/Share
|
|
Feb 17
2021
|
Erick Wayne De Vinney Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,864
-1.36%
|
$33,552
$18.7 P/Share
|
|
Feb 17
2021
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
SELL
Payment of exercise price or tax liability
|
Direct |
951
-3.41%
|
$17,118
$18.71 P/Share
|
|
Feb 17
2021
|
Angelo Scopelianos Chief R&D Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
406
-5.45%
|
$7,308
$18.71 P/Share
|
|
Feb 16
2021
|
Isabelle Billet Chief Strategy and BD Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,325
+10.3%
|
-
|
|
Feb 16
2021
|
Karen L. Zaderej CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,999
+2.33%
|
-
|
|
Feb 16
2021
|
Peter J Mariani EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,812
+22.02%
|
-
|
|
Feb 16
2021
|
Maria D. Martinez Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,325
+18.11%
|
-
|
|
Feb 16
2021
|
Gregory Gene Freitag Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,161
+1.01%
|
-
|
|
Feb 16
2021
|
Michael Patrick Donovan VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,605
+2.93%
|
-
|
|
Feb 16
2021
|
Eric Sandberg Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,531
+38.02%
|
-
|
|
Feb 16
2021
|
Erick Wayne De Vinney Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,231
+4.27%
|
-
|
|
Feb 16
2021
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
BUY
Grant, award, or other acquisition
|
Direct |
3,111
+9.99%
|
-
|
|
Feb 16
2021
|
Angelo Scopelianos Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,325
+15.1%
|
-
|
|
Feb 05
2021
|
Michael Patrick Donovan VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
5,190
-11.28%
|
$98,610
$19.81 P/Share
|
|
Feb 05
2021
|
Michael Patrick Donovan VP Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+30.29%
|
$100,000
$5.14 P/Share
|
|
Jan 08
2021
|
Karen L. Zaderej CEO |
SELL
Open market or private sale
|
Direct |
65,000
-9.64%
|
$1,300,000
$20.0 P/Share
|